The start up was wholly funded by Oman banks with significant share-holding by Oman investors. It was a major breakthrough in international vaccine pricing and supply to poor countries worldwide. Today the company is a wholly owned subsidiary of Sanofi group of France.
from Economy-News-Economic Times https://ift.tt/SR2OMo4
via
No comments:
Post a Comment